HOME >> MEDICINE >> NEWS
Cholesterol fighting drugs may also have protective effects against multiple sclerosis

ST. PAUL, MN A group of cholesterol-lowering drugs may also effectively interfere with the progression of multiple sclerosis (MS). These drugs, known as statins, greatly reduce hardening of the arteries (atherosclerosis) and heart disease, mainly by their cholesterol and low-density lipoprotein-lowering properties. A study published in the October 8 issue of Neurology, the journal of he American Academy of Neurology, indicates that statins may also have therapeutic potential for a variety of immunity related disorders such as MS, rheumatoid arthritis, type I diabetes and graft-rejection in organ transplantation.

Researchers from Austria and Germany investigated the impact of statins on a variety of immune responses in MS, comparing the effects with those induced by interferon-beta, an established disease-modifying therapy in MS. Using blood drawn from 74 MS patients and 25 healthy donors, tests were performed in vitro with lovastatin, simvastatin, mevastatin, and interferon alone, and statins plus interferon. "Our study shows that statins modify several molecules of the immune system involved in the disease progression of MS, independent of their use with interferon," notes study author Juan Jos Archelos, MD, of Karl-Franzens University, Graz, Austria. "The potent anti-inflammatory effects of statins are remarkable, and even more effective when combined with interferon-beta."

This study indicates that these well-established therapeutic agents may be a useful stand-alone or add-on therapy to interferon-beta, with the added advantage of an oral versus injectible delivery. While study results are encouraging, study authors caution that much more research is necessary to establish the precise mechanisms by which statins induce these anti-inflammatory effects.


'"/>

Contact: Cheryl Alementi
calementi@aan.com
651-695-2737
American Academy of Neurology
7-Oct-2002


Page: 1

Related medicine news :

1. Cholesterol under-treated in high-risk women in managed care study
2. Cholesterol-lowering drug may also reduce risk of blood clots
3. Cholesterol-lowering drug may slow Alzheimers progression
4. Cholesterol-lowering medications may reduce risk of glaucoma
5. Cholesterol levels fluctuate with the seasons
6. Cholesterol-lowering drugs may help stroke patients get well
7. Cholesterol drugs may lower risk for mental impairment after stroke
8. Cholesterol drug increases pain-free walking distance
9. Cholesterol drug helps heart failure patients without high cholesterol
10. Cholesterol drug could lead to new therapy for multiple sclerosis
11. Cholesterol-lowering drugs safe and effective in children

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/20/2017)... 2017 (PRWEB) , ... July ... ... global provider of enterprise-grade IT operations analytics and application performance monitoring (APM) ... of world’s largest healthcare services providers. , According to Peter Ohrenberger, sales ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... For individuals ... utmost importance. The adjustable beds used in such facilities are specially designed to accommodate ... adequate arm support. , An inventor from Rochester, Ind., has invented the patent-pending ...
(Date:7/20/2017)... ... July 20, 2017 , ... Team Type 1 Foundation, a ... for everyone affected by diabetes, is teaming up with a Microsoft Corp. employee-led hackathon ... off on July 24th. , “Team Type 1’s mission overlaps seamlessly with Microsoft’s ...
(Date:7/20/2017)... ... July 20, 2017 , ... Vixiar Medical, Inc. , ... systems for monitoring cardiopulmonary diseases, announced today that it has raised seed round ... submissions and fund final engineering and initial production of the Company’s first product, ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... FDAnews Webinar**, Aug. 9, 2017 — 1:30 p.m. – 3:00 p.m. ET, ... inspections and boosting quality. , It’s known as the “CY2016 Annual FDA Medical ...
Breaking Medicine News(10 mins):
(Date:7/19/2017)... 2017  Mako Medical Laboratories partnered with Secretary Strickland, ... Assistance Fund (MFA) to bring 140 soldiers back home ... their families one last time before being deployed. Mako ... and logistics needed for these soldiers. "Mako Medical Laboratories ... families. We just wish we could bring them all ...
(Date:7/13/2017)... , July 13, 2017  Centurion Medical Products, a leader in ... DisImpactor ® fecal impaction removal device for hospice patient care. ... Centurion Medical ... Patient pain management and emotional comfort ... can help alleviate patient pain while preventing unneeded emergency department admission ...
(Date:7/11/2017)... , July 11, 2017 Zymo Research Corp., also known as ... can quantify biological aging in a precise manner using the myDNAge ™ ... Horvath , a professor of human genetics and biostatistics at the ... of Public Health , Zymo Research,s proprietary DNAge ™ technology is ... ...
Breaking Medicine Technology:
Cached News: